Peroxisome Proliferator-Activated Receptors (PPARs) and PPAR Agonists: The Future in Dermatology Therapeutics?

    Mrinal Gupta, Vikram K. Mahajan, Karaninder S Mehta … Ritu Rawat
    Studysummary This review discusses the role of peroxisome proliferator-activated receptors and their agonists in dermatology but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Contributions of Peroxisome Proliferator-Activated Receptor β/δ to Skin Health and Disease BioMolecular Concepts · 2012
    2. Lichen Planopilaris Treated With a Peroxisome Proliferator-Activated Receptor Gamma Agonist Archives of dermatology · 2009
    3. Functions of Peroxisome Proliferator-Activated Receptors in Skin Homeostasis Lipids · 2004

    Related research 1

    1. Peroxisome Proliferator-Activated Receptors (PPARs) and PPAR Agonists: The Future in Dermatology Therapeutics? Archives of dermatological research · 2015